Endobronchial Valves Market

Endobronchial Valves Market Outlook (2023 to 2033)

The worldwide Endobronchial valve arcade is expected to grow with a CAGR of 5.8% in the forecast period 2023- 2033. The market is valued at USD 178.78 million at present in 2023. Further, the industry is anticipated to surpass a valuation of USD 314.18 million by end of 2033.

The global market for endobronchial valves is still in the nascent stage. Due to the increasing demand, manufacturers of endobronchial valve systems are mainly focused on clinical trials and research and development.

In the forthcoming years, the global market is expected to witness the entry of a few new market players, which will increase the competition in the market. With the growing global population, predominantly geriatric, who are more susceptible to lung disease, the market is expected to grow at a steady speed.

Among the two product types, due to the ease in implanting the duckbill-shaped endobronchial valves is expected to be the leading segment in the global market over the forecast period. The ongoing clinical trials in various regions as such North America and Europe, especially in the U.K., are projected to offer new growth opportunities for the manufacturers operating in the market.

Report Attributes	Details
Market size (2023 A)	USD 178.78 million
Base Year for Estimation	2023
Forecast duration for this research	2023-2033
Forecasted Market value (2033 F)	USD 314.18 million
Global Market Growth rate (2023-2033 E)	CAGR of 5.8%
Key Companies Profiled	Pulmonx Corporation (Zephyr), Spiration Inc

What makes the Endobronchial valve preferable over thoracoscopic surgery?

Endobronchial valves are specially designed one-way valves that allow the exhaled air to exit the lungs, but restrict the entry of inhaled air to the lung compartment. The endobronchial valve is used to decrease the lung volume in the condition of lung disease or more specifically emphysema. A common endoscopic approach is prescribed rather than thoracoscopic lung volume reduction surgery.

Endoscopic lung volume reduction surgery (LVRS) is a minimally invasive procedure that can be used to treat severe emphysema. It involves inserting a small camera and instruments through the mouth or nose to remove damaged tissue from the lungs.

This approach is preferred by doctors because it is less invasive than thoracoscopic LVRS, which requires a larger incision in the chest wall. Endoscopic LVRS also has a shorter recovery time and fewer risks of complications. Additionally, endoscopic LVRS can be used to treat more areas of the lungs than thoracoscopic LVRS.

What are the demand drivers of the market?

The major factor expected to drive the growth of the market is growing awareness regarding procedures for bronchoscopic lung volume reduction in various lung-related diseases. The increasing prevalence of tobacco smoking worldwide is consequently expected to contribute to the growth of the market.

The insertion of the endobronchial valve is performed by a delivery catheter, which is passed from the bronchoscope. This valve is designed in such a way that it only prevents air uptake or inflation during the inhalation process, and allows the mucosa and exhaled air to exit or the lungs to deflate during the process of exaltation. Moreover, it comes in different shapes and designs based on their use. Currently, such valves are designed in duckbill and umbrella shapes.

Chronic obstructive pulmonary disease (COPD) is one of the major lung disorders. With the growing geriatric population, who are more commonly susceptible to lung disease, the demand is expected to increase at a linear speed. Besides, growing air pollution has a significant impact on the increasing number of patients suffering from lung disorders, particularly severe emphysema, and advanced emphysema.

This is also considered as one of the major factors fuelling the growth of the global market over the forecast period. The efficiency of these valves compared to the standard medical care in lung volume reduction methods and emphysema treatment is the other factor expected to propel the growth of the market over the forecast period.

However, the high cost associated with the procedure coupled with the post-operative adhesion issues associated with the valve are factors expected to restrict the growth of the market over the forecast period.

Segmentation

• By Product Type :

  • Duckbill-shaped
  • Umbrella-shaped

• By End user :

  • Hospitals
  • Clinical Research Center
  • Ambulatory Surgery Center
  • Others

• By Region :

  • North America 
  • Latin America
  • Europe 
  • CIS & Russia
  • Asia Pacific
  • Japan
  • Middle East and Africa